跳至主要内容
临床试验/NCT02151136
NCT02151136终止4 期

Be Sweet to Toddlers During Needles: RCT of Sucrose Compared to Placebo

Children's Hospital of Eastern Ontario1 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2015年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
86
试验地点
1
主要终点
Cry duration

研究概览

简要总结

The purpose of this study is to determine whether sugar water (24% sucrose) effectively reduces pain in children ages 12 to 36 months undergoing venipuncture, as measured by pain scores and cry duration.

详细描述

Background:

Hospitalized children and children undergoing medical care as outpatients are frequently required to undergo needle-related procedures, such as venipuncture for diagnostic purposes and ongoing monitoring (Ellis, Sharp, Newhook, & Cohen, 2004). This procedure causes considerable pain and distress, especially in young children (Humphrey, Boon, van Linden van den Heuvell, & van de Wiel, 1992). Children rate needles as being the most distressing aspect of hospitalization (Kortesluoma & Nikkonen, 2006; Kortesluoma & Nikkonen, 2004), yet they are the most frequently performed skin-breaking procedure for hospitalized children (Cummings, Reid, Finley, McGrath, & Ritchie, 1996; Ellis, et al., 2004; Rennick, McHarg, Dell'Api, Johnston, & Stevens, 2008; Stevens et al., 2011). It is estimated that one-quarter of adults have developed a fear needles, most likely developed during childhood (Taddio et al., 2010; Wright, Yelland, Heathcote, Ng, & Wright, 2009). Being afraid of needles increases the risk of avoidance of needles for immunizations and medical care (Taddio et al., 2009; Wright, et al., 2009). It is therefore crucial that health care researchers and clinicians determine effective pain management strategies for young children, and consistently use such strategies in clinical care.

Rationale:

There is a paucity of evidence to support efficacy and feasibility of pain management strategies during needle-related painful procedures in young children, and uncertainties exist regarding analgesic effects of sweet solutions beyond infancy.

Objectives:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
12 Months 至 36 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Children aged 12-36 months, inclusive
  • Children who are patients at CHEO in the 4 East/West or 5 East wards (and overflow unit, when applicable), and the Medical Day Unit
  • Children who require venipuncture for the purpose of medically required venous blood sampling
  • With the exception of the age criteria, children who are eligible to receive sucrose as per the Sucrose CHEO policy for infants
  • Children who have their venipuncture performed by hospital-employed phlebotomists or registered nurses (to ensure standardization of the blood collection procedure)
  • Parents/guardians and children must also be able to understand English or French

排除标准

  • Children who have received a muscle relaxant, opioid analgesic or sedative in the past 24 hours (to ensure there is no interaction effect of these medications which may impact on toddlers' ability to mount a behavioral response to pain)
  • Children who are ineligible to receive sucrose as per the Sucrose CHEO policy
  • Children who are already consuming sweet fluids or foods, or if the mother wishes to breast feed during the procedure will also be excluded
  • Children with known or suspected fructose intolerance

研究组 & 干预措施

24% sucrose + standard care

Experimental

In addition to standard care (topical anesthetic (Ametop or EMLA) + upright holding + distraction + pacifier, if used), a maximum of 2 ml 24% sucrose will be administered orally in 0.25 ml aliquots 2 minutes prior to the needle insertion, at the time of needle insertion, and repeated at 2 minute intervals until the completion of the procedure

干预措施: 24% sucrose (Drug)

24% sucrose + standard care

Experimental

In addition to standard care (topical anesthetic (Ametop or EMLA) + upright holding + distraction + pacifier, if used), a maximum of 2 ml 24% sucrose will be administered orally in 0.25 ml aliquots 2 minutes prior to the needle insertion, at the time of needle insertion, and repeated at 2 minute intervals until the completion of the procedure

干预措施: Standard care (Other)

Sterile water + standard care

Placebo Comparator

In addition to standard care (topical anesthetic (Ametop or EMLA) + upright holding + distraction + pacifier, if used), a maximum of 2 ml sterile water will be administered orally in 0.25 ml aliquots 2 minutes prior to the needle insertion, at the time of needle insertion, and repeated at 2 minute intervals until the completion of the procedure

干预措施: Sterile water (Drug)

Sterile water + standard care

Placebo Comparator

In addition to standard care (topical anesthetic (Ametop or EMLA) + upright holding + distraction + pacifier, if used), a maximum of 2 ml sterile water will be administered orally in 0.25 ml aliquots 2 minutes prior to the needle insertion, at the time of needle insertion, and repeated at 2 minute intervals until the completion of the procedure

干预措施: Standard care (Other)

结局指标

主要结局

Cry duration

时间窗: Cry time will be measured from the time of needle insertion up to 30 seconds after the end of the venipuncture procedure

Cry is a valid measure of distress in young children and is an objective and easily measurable parameter.

次要结局

  • FLACC (Face, Legs, Arms, Crying, Consolability)(FLACC scores will be completed before and during the procedure and up to one minute after the end of the venipuncture procedure)
  • MBPS (Modified Behavioural Pain Scale)(MBPS scores will be completed before and during the procedure and up to one minute after the end of the venipuncture procedure)
  • Child's compliance with intervention(up to one minute)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Denise Harrison

Chair in Nursing Care of Children, Youth and Families

Children's Hospital of Eastern Ontario

研究点 (1)

Loading locations...

相似试验